Comprehensive Cancer Screening: Genetic test available in Dubai, UAE

Comprehensive Cancer Panel

Comprehensive Cancer Panel is a next generation full gene sequencing hereditary cancer panel that simultaneously analyzes 122 genes associated with the most common hereditary cancers such as Breast, Ovarian, Colorectal, Endometrial, Melanoma, Pancreatic, Gastric, Prostrate, Thyroid, and many more. About 10% of all cancer cases are due to hereditary cancer. The identification of the genetic cause of cancer in these patients allows the development of a personalized plan for clinical management for the affected patient and family members.

  • Additional information

Additional information

Test Code

E3303

Application(s):

• Genetic testing for cancer is recommended for patients with a personal or a family history suggestive of hereditary cancer: Patients with cancer at an early age or with bilateral (more than one primary) cancer or patients with several family members with similar cancer or other manifestations provocative of cancer syndromes.
• The identification of the gene responsible for the observed cancer might influence the treatment of the cancer patient (radiotherapy, surgical or pharmacological management).
• Some mutations are associated with several types of cancer,
therefore the identification of the affected gene will result in a preventive plan that involves the different organs that might be affected.

• When the family mutation is known, unaffected individuals can be tested to start risk-reducing interventions before any cancer manifestation.

Technique:

NGS Full Sequencing + Deletion/Duplication

Sample Type:

Blood in EDTA

Sample Report

http://www.easternbiotech.com/reports/Model-Comprehensive-Cancer.pdf

TAT

3-4 Weeks + Shipping